Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Baricitinib may effectively treat oral lichen planus.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Three compounds from Dadap leaves may help treat hair loss.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

ITK inhibitors may effectively treat alopecia areata.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.